Imaging of Protein Synthesis:In VitroandIn VivoEvaluation of44Sc ...ur.booksc.eu › book
ur.booksc.eu
Imaging of Protein Synthesis:In VitroandIn VivoEvaluation of44Sc-DOTA-Puromycin | Sebastian Eigner, Denis R. Beckford Vera, Marco Fellner, ...
Table of Contents: Theranostics, Gallium-68, and other radionuclides
library.villanova.edu
... and 2-Fluoro-[3H]tyrosine / Sebastian Eigner, Denis R. Beckford Vera, ... Sebastian Eigner, Katerina Eigner Henke, Rene Leyva Montaña and Frantisek ...
Theranostics, Gallium-68, and Other Radionuclides: A Pathway ...google.com
books.google.com
... Sebastian Eigner, Denis R. Beckford Vera, Marco Fellner, Natalia S. Loktionova, Markus Piel, Frantisek Melichar, Fig. 2 Active ribosomal complex; modified ...
In Vitro and In Vivo Evaluation of Sc-DOTA-PuromycinProQuest
search.proquest.com
von S Eigner · · Zitiert von: 45 — Imaging of Protein Synthesis: In Vitro and In Vivo. Evaluation of Sc-DOTA-Puromycin. Sebastian Eigner,. 1. Denis R. Beckford Vera,.
Nuclear Medicine and Biology | Vol 39, Issue 1, Pages ...ScienceDirect
www.sciencedirect.com
Denis R. Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Ondrej Lebeda, ... Milos Beran. Pages 3-13: View PDF. Article preview.
Imaging of Protein Synthesis: In Vitro In Vivo Evaluation of Sc …
download.uni-mainz.de
WebSebastian Eigner,1 Denis R. Beckford Vera,1 Marco Fellner,2 Natalia S. Loktionova,2 Markus Piel,1 Ondrej Lebeda,1 Frank Rösch,2 Tobias L. Roß,2 Katerina Eigner Henke1 …
Measurement of Protein Synthesis: In Vitro Comparison of 68 Ga …
bibliographie.ub.uni-mainz.de
WebSebastian Eigner Denis R Beckford Vera Marco Fellner Natalia S Loktionova Markus Piel Frantisek Melichar Frank Rösch Tobias L Roß Ondrej Lebeda Katerina Eigner Henke …
Theranostics, Gallium-68, and Other RadionuclidesSpringer
link.springer.com
von RP Baum · Zitiert von: 42 — Sebastian Eigner, Denis R. Beckford Vera, Marco Fellner, Natalia S ... Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Rene Leyva Montaña, Frantisek ... von RP Baum · Zitiert von: 42 — Sebastian Eigner, Denis R. Beckford Vera, Marco Fellner, Natalia S ... Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Rene Leyva Montaña, Frantisek ...
Alle Infos zum Namen "Sebastian Eigner"
Preclinical Evaluation of 177Lu-NimotuzumabMary Ann Liebert, Inc.
www.liebertpub.com
von DRB Vera · · Zitiert von: 25 — Denis Rolando Beckford Vera,1 Sebastian Eigner,1 Milos Beran,1,2 Katerina Eigner Henke,1,2. Alice Laznickova,3 Milan Laznicek,3 Frantisek Melichar,1,2 and ... von DRB Vera · · Zitiert von: 25 — Denis Rolando Beckford Vera,1 Sebastian Eigner,1 Milos Beran,1,2 Katerina Eigner Henke,1,2. Alice Laznickova,3 Milan Laznicek,3 Frantisek Melichar,1,2 and ...
Preclinical evaluation of [sup.177]Lu-Nimotuzumab: a ...Gale
go.gale.com
von DRB Vera · · Zitiert von: 25 — Adv Drug Delivery Rev 2002;54:542. Denis Rolando Beckford Vera [1] Sebastian Eigner, [1] Milos Beran, [1,2] Katerina Eigner Henke, [1,2] Alice Laznickova ... von DRB Vera · · Zitiert von: 25 — Adv Drug Delivery Rev 2002;54:542. Denis Rolando Beckford Vera [1] Sebastian Eigner, [1] Milos Beran, [1,2] Katerina Eigner Henke, [1,2] Alice Laznickova ...
Study of biological behaviour of the DOTA-Nimotuzumab ...Journal of Nuclear Medicine
jnm.snmjournals.org
von DB Vera · · Zitiert von: 1 — Denis Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Frantisek Melichar and Miloš Beran. Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1586;. von DB Vera · · Zitiert von: 1 — Denis Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Frantisek Melichar and Miloš Beran. Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1586;.
in vitro and in vivo evaluation of (44)Sc-DOTA-puromycinNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von S Eigner · · Zitiert von: 47 — Sebastian Eigner , Denis R Beckford Vera, Marco Fellner, Natalia S Loktionova, Markus Piel, Ondrej Lebeda, Frank Rösch, Tobias L Roß, Katerina Eigner ... von S Eigner · · Zitiert von: 47 — Sebastian Eigner , Denis R Beckford Vera, Marco Fellner, Natalia S Loktionova, Markus Piel, Ondrej Lebeda, Frank Rösch, Tobias L Roß, Katerina Eigner ...
in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von S Eigner · · Zitiert von: 3 — Sebastian Eigner , Denis R Beckford Vera, Marco Fellner, Natalia S Loktionova, Markus Piel, Frantisek Melichar, Frank Rösch, Tobias L Roß, Ondrej Lebeda, ... von S Eigner · · Zitiert von: 3 — Sebastian Eigner , Denis R Beckford Vera, Marco Fellner, Natalia S Loktionova, Markus Piel, Frantisek Melichar, Frank Rösch, Tobias L Roß, Ondrej Lebeda, ...
68 Ga-DOTA-Puromycin: In vivo imaging of bacterial infectionJournal of Nuclear Medicine
jnm.snmjournals.org
von S Eigner · · Zitiert von: 5 — Ga-DOTA-Puromycin: In vivo imaging of bacterial infection. Sebastian Eigner, Denis Beckford Vera, Ondrej Lebeda and Katerina Eigner Henke. Journal of ...
(177)Lu/ (90)Y intermediate-affinity monoclonal antibodies targeting ...pubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Authors. Denis R Beckford Vera , Sebastian Eigner, Katerina Eigner Henke, Rene Leyva Montaña, Frantisek Melichar, Milos Beran ...
Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting...
www.infona.pl
less. Denis R. Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Ondrej Lebeda, Frantisek Melichar, Milos Beran · Details · Authors · Fields of science ...
Preclinical evaluation of [sup.177]Lu-Nimotuzumab: a potential tool...
go.gale.com
Authors: Denis Rolando Beckford Vera, Sebastian Eigner, Milos Beran, Katerina Eigner Henke, Alice Laznickova and Milan Laznicek. Date: June
Verwandte Suchanfragen zu Sebastian Eigner
| Markus Piel Frank Rösch Kata Puskaric | Katerina Eigner Kevin Mayr Ulrike Eigner | Gerhard Eigner Tilo Jentzsch Claus Eigner |
Person "Eigner" (6) Vorname "Sebastian" (47648) Name "Eigner" (471) |
sortiert nach Relevanz / Datum